Origin.bio GmbH
Origin.Bio, launched in 2021, connects bioengineers with nature to create synthetic microorganisms for producing ingredients traditionally made through chemical processes.
Introduction
Origin.Bio, launched in 2021, is a pioneering synthetic biology company that bridges the gap between bioengineers and nature. This innovative firm develops synthetic microorganisms capable of producing many of the same ingredients currently manufactured through traditional chemical industrial processes, but with significant...
Information
More Websites
Richard Kühn GmbH, a 4th generation owned company, combines tradition with modern enterprise promise.
Tobacco Pharmaceutical Technology Co., Ltd. develops and produces pharmaceutical intermediaries, with R&D partnerships and environment-friendly practices.
proMtec supplies precise liquid density/concentration measurement using microwave transmission in processes.